224 related articles for article (PubMed ID: 19413593)
21. Magnesium ions and opioid agonist activity in streptozotocin-induced hyperalgesia.
Bujalska M; Malinowska E; Makulska-Nowak H; Gumułka SW
Pharmacology; 2008; 82(3):180-6. PubMed ID: 18701828
[TBL] [Abstract][Full Text] [Related]
22. Mechanical hyperalgesia correlates with insulin deficiency in normoglycemic streptozotocin-treated rats.
Romanovsky D; Cruz NF; Dienel GA; Dobretsov M
Neurobiol Dis; 2006 Nov; 24(2):384-94. PubMed ID: 16935517
[TBL] [Abstract][Full Text] [Related]
23. Pharmacological characterization of standard analgesics on mechanical allodynia in streptozotocin-induced diabetic rats.
Yamamoto H; Shimoshige Y; Yamaji T; Murai N; Aoki T; Matsuoka N
Neuropharmacology; 2009 Sep; 57(4):403-8. PubMed ID: 19591853
[TBL] [Abstract][Full Text] [Related]
24. Modulatory effect of the PDE-5 inhibitor sildenafil in diabetic neuropathy.
Patil CS; Singh VP; Singh S; Kulkarni SK
Pharmacology; 2004 Nov; 72(3):190-5. PubMed ID: 15452368
[TBL] [Abstract][Full Text] [Related]
25. Lycopene attenuates thermal hyperalgesia in a diabetic mouse model of neuropathic pain.
Kuhad A; Sharma S; Chopra K
Eur J Pain; 2008 Jul; 12(5):624-32. PubMed ID: 18055235
[TBL] [Abstract][Full Text] [Related]
26. Minocycline attenuates the development of diabetic neuropathic pain: possible anti-inflammatory and anti-oxidant mechanisms.
Pabreja K; Dua K; Sharma S; Padi SS; Kulkarni SK
Eur J Pharmacol; 2011 Jul; 661(1-3):15-21. PubMed ID: 21536024
[TBL] [Abstract][Full Text] [Related]
27. Relevance of hyperglycemia to early mechanical hyperalgesia in streptozotocin-induced diabetes.
Romanovsky D; Hastings SL; Stimers JR; Dobretsov M
J Peripher Nerv Syst; 2004 Jun; 9(2):62-9. PubMed ID: 15104693
[TBL] [Abstract][Full Text] [Related]
28. Neuroprotective effect of naringin by modulation of endogenous biomarkers in streptozotocin induced painful diabetic neuropathy.
Kandhare AD; Raygude KS; Ghosh P; Ghule AE; Bodhankar SL
Fitoterapia; 2012 Jun; 83(4):650-9. PubMed ID: 22343014
[TBL] [Abstract][Full Text] [Related]
29. Antinociceptive property of Emblica officinalis Gaertn (Amla) in high fat diet-fed/low dose streptozotocin induced diabetic neuropathy in rats.
Kumar NP; Annamalai AR; Thakur RS
Indian J Exp Biol; 2009 Sep; 47(9):737-42. PubMed ID: 19957886
[TBL] [Abstract][Full Text] [Related]
30. The impact of bodyweight and body condition on behavioral testing for painful diabetic neuropathy in the streptozotocin rat model.
Hoybergs YM; Biermans RL; Meert TF
Neurosci Lett; 2008 May; 436(1):13-8. PubMed ID: 18375060
[TBL] [Abstract][Full Text] [Related]
31. Quercetin, a bioflavonoid, attenuates thermal hyperalgesia in a mouse model of diabetic neuropathic pain.
Anjaneyulu M; Chopra K
Prog Neuropsychopharmacol Biol Psychiatry; 2003 Sep; 27(6):1001-5. PubMed ID: 14499317
[TBL] [Abstract][Full Text] [Related]
32. Antinociceptive effect of Teucrium polium leaf extract in the diabetic rat formalin test.
Baluchnejadmojarad T; Roghani M; Roghani-Dehkordi F
J Ethnopharmacol; 2005 Feb; 97(2):207-10. PubMed ID: 15707753
[TBL] [Abstract][Full Text] [Related]
33. Antinociceptive efficacy of lacosamide in a rat model for painful diabetic neuropathy.
Beyreuther B; Callizot N; Stöhr T
Eur J Pharmacol; 2006 Jun; 539(1-2):64-70. PubMed ID: 16682022
[TBL] [Abstract][Full Text] [Related]
34. Neurobiological effects of pulsed magnetic field on diabetes-induced neuropathy.
Mert T; Gunay I; Ocal I
Bioelectromagnetics; 2010 Jan; 31(1):39-47. PubMed ID: 19593780
[TBL] [Abstract][Full Text] [Related]
35. Antinociceptive and antihyperglycemic effects of Melissa officinalis essential oil in an experimental model of diabetes.
Hasanein P; Riahi H
Med Princ Pract; 2015; 24(1):47-52. PubMed ID: 25402675
[TBL] [Abstract][Full Text] [Related]
36. Impaired formalin-evoked changes of spinal amino acid levels in diabetic rats.
Malmberg AB; O'Connor WT; Glennon JC; Ceseña R; Calcutt NA
Brain Res; 2006 Oct; 1115(1):48-53. PubMed ID: 16920081
[TBL] [Abstract][Full Text] [Related]
37. Effects of rosmarinic acid on an experimental model of painful diabetic neuropathy in rats.
Hasanein P; Mohammad Zaheri L
Pharm Biol; 2014 Nov; 52(11):1398-402. PubMed ID: 25026351
[TBL] [Abstract][Full Text] [Related]
38. Tocotrienol attenuates oxidative-nitrosative stress and inflammatory cascade in experimental model of diabetic neuropathy.
Kuhad A; Chopra K
Neuropharmacology; 2009 Sep; 57(4):456-62. PubMed ID: 19555701
[TBL] [Abstract][Full Text] [Related]
39. Antinociceptive activity of the N-methyl-D-aspartate receptor antagonist N-(2-Indanyl)-glycinamide hydrochloride (CHF3381) in experimental models of inflammatory and neuropathic pain.
Villetti G; Bergamaschi M; Bassani F; Bolzoni PT; Maiorino M; Pietra C; Rondelli I; Chamiot-Clerc P; Simonato M; Barbieri M
J Pharmacol Exp Ther; 2003 Aug; 306(2):804-14. PubMed ID: 12750440
[TBL] [Abstract][Full Text] [Related]
40. Novel protein kinase C-beta isoform selective inhibitor JTT-010 ameliorates both hyper- and hypoalgesia in streptozotocin- induced diabetic rats.
Sasase T; Yamada H; Sakoda K; Imagawa N; Abe T; Ito M; Sagawa S; Tanaka M; Matsushita M
Diabetes Obes Metab; 2005 Sep; 7(5):586-94. PubMed ID: 16050952
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
